Clinical Trial Update: Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis

View source ↗

Summary

Clinical trial update on SIMBA Capsule evaluating small intestinal dysbiosis, with recruitment ongoing for several gastrointestinal and metabolic conditions inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease
• Crohn Disease
• Functional Dyspepsia
• Irritable Bowel Syndrome
• Type 2 Diabetes Mellitus
• Ulcerative Colitis

Drugs mentioned

• SIMBA Capsule (oral nutritional supplement)

Snippet

Sponsor: Nimble Science Ltd. | Conditions: Irritable Bowel Syndrome, Crohn Disease | Status: RECRUITING